» Articles » PMID: 33844936

Lessons from Cancer Metabolism for Pulmonary Arterial Hypertension and Fibrosis

Overview
Date 2021 Apr 12
PMID 33844936
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolism is essential for a living organism to sustain life. It provides energy to a cell by breaking down compounds (catabolism) and supplies building blocks for the synthesis of macromolecules (anabolism). Signal transduction pathways tightly regulate mammalian cellular metabolism. Simultaneously, metabolism itself serves as a signaling pathway to control many cellular processes, such as proliferation, differentiation, cell death, gene expression, and adaptation to stress. Considerable progress in the metabolism field has come from understanding how cancer cells co-opt metabolic pathways for growth and survival. Recent data also show that several metabolic pathways may participate in the pathogenesis of lung diseases, some of which could be promising therapeutic targets. In this translational review, we will outline the basic metabolic principles learned from the cancer metabolism field as they apply to the pathogenesis of pulmonary arterial hypertension and fibrosis and will place an emphasis on therapeutic potential.

Citing Articles

Metabolic pathways, genomic alterations, and post-translational modifications in pulmonary hypertension and cancer as therapeutic targets and biomarkers.

Zhang X, Fu Z, Wang H, Sheng L Front Pharmacol. 2024; 15:1490892.

PMID: 39635438 PMC: 11614602. DOI: 10.3389/fphar.2024.1490892.


Oroxylin A, a broad‑spectrum anticancer agent, relieves monocrotaline‑induced pulmonary arterial hypertension by inhibiting the Warburg effect in rats.

Wang Y, Fan Y, Zhou Y, Chen T, Xu S, Liu J Mol Med Rep. 2024; 30(5).

PMID: 39219283 PMC: 11391512. DOI: 10.3892/mmr.2024.13319.


Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial Hypertension.

Jankowski K, Jagana V, Bisserier M, Hadri L Biomedicines. 2024; 12(1).

PMID: 38275371 PMC: 10813728. DOI: 10.3390/biomedicines12010010.


Evidence for Hypoxia-Induced Shift in ATP Production from Glycolysis to Mitochondrial Respiration in Pulmonary Artery Smooth Muscle Cells in Pulmonary Arterial Hypertension.

Akagi S, Nakamura K, Kondo M, Hirohata S, Udono H, Nishida M J Clin Med. 2023; 12(15).

PMID: 37568430 PMC: 10419513. DOI: 10.3390/jcm12155028.


Multi‑omics analysis of right ventricles in rat models of pulmonary arterial hypertension: Consideration of mitochondrial biogenesis by chrysin.

Kobayashi T, Kim J, Naito A, Yanagisawa A, Jujo-Sanada T, Kasuya Y Int J Mol Med. 2022; 49(5).

PMID: 35315498 PMC: 8989426. DOI: 10.3892/ijmm.2022.5124.


References
1.
Bueno M, Lai Y, Romero Y, Brands J, St Croix C, Kamga C . PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J Clin Invest. 2015; 125(2):521-38. PMC: 4319413. DOI: 10.1172/JCI74942. View

2.
Xiao H, Huang X, Wang S, Liu Z, Dong R, Song D . Metformin ameliorates bleomycin-induced pulmonary fibrosis in mice by suppressing IGF-1. Am J Transl Res. 2020; 12(3):940-949. PMC: 7137034. View

3.
Porporato P, Payen V, Perez-Escuredo J, De Saedeleer C, Danhier P, Copetti T . A mitochondrial switch promotes tumor metastasis. Cell Rep. 2014; 8(3):754-66. DOI: 10.1016/j.celrep.2014.06.043. View

4.
Michelakis E, McMurtry M, Wu X, Dyck J, Moudgil R, Hopkins T . Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation. 2002; 105(2):244-50. DOI: 10.1161/hc0202.101974. View

5.
Dromparis P, Michelakis E . Mitochondria in vascular health and disease. Annu Rev Physiol. 2012; 75:95-126. DOI: 10.1146/annurev-physiol-030212-183804. View